http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.934|20240711

name
T2DMMedsBenefittingCKDStages23And4WithEGFR20MLMin
package
us.nlm.vsac@0.21.0
status
active
date
2024-07-11 05:03:01.0

T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min